Clinical trial
Prospective Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis
NCT03847220 is registered in ClinicalTrials.gov with Spanish Breast Cancer Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis
- Lead sponsor
- Spanish Breast Cancer Research Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 23, 2007
- Completion date
- July 7, 2012
- Enrollment
- 241 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
breast carcinoma metastatic to the bone